Tag:
ocriplasmin
Latest Headlines
Latest Headlines
ThromboGenics prepares for future FDA approval filing
As Belgian biotech ThromboGenics sets its sights on approval for its eye disorder treatment ocriplasmin, the company isn't worrying about its cash flow. According to a statement, it is prepared for
